Polypharmacy in the Elderly of an Educational Program in the Brazilian Capital: A Cross-Sectional Study
DOI:
https://doi.org/10.30827/ars.v65i4.30673Keywords:
polypharmacy, aged, aging, drug utilization, comprehensive health care, health policyAbstract
Introduction: The elderly correspond to the most medicalized group in society. Therefore, studies related to the use of medicines are important to improve policies that guarantee comprehensive care. The objective of this study was to investigate the polypharmacy among elderly individuals attending an educational program in the Federal District of Brazil and estimate the prevalence and associated variables.
Method: This is a cross-sectional study with 150 elderly individuals whose data were collected in the period from December 2022 to April 2023 by means of telephone calls.
Results: The prevalence of polypharmacy was estimated in 18.7%. The variables showing a positive association with polypharmacy were the following: health self-perceived as bad or very bad (PR = 8.9; 95 % CI 4.78 – 16.70), smoking (PR = 2.50; 95 % CI 1.06 – 5.89), systemic arterial hypertension (PR = 3.55; 95 % CI 1.40 – 9.00), diabetes mellitus (PR = 3.46; 95 % CI 1.67 – 7.18), depression (PR = 3.32; 95 %CI 1.58 – 6.75), multimorbidity (PR = 8.97; 95 % CI 1.26 – 64.10) and Charlson Comorbidity Index equal to or greater than 3 (PR = 7.21; 95 % CI 1.14 – 26.17).
Conclusions: The prevalence of polypharmacy and associated variables are corroborated by other Brazilian studies. Therefore, it is pointed out that healthcare teams should pay attention to this aspect of geriatric pharmacotherapy to favour the responsible use of medications and yield positive clinical outcomes.
Downloads
References
Kawada T. Polypharmacy, frailty and disability-free survival in older adults. Arch Gerontol Geriatr. 2023; 110:104983. doi: 10.1016/j.archger.2023.104983.
Ramos LR. Determinant factors for healthy aging among senior citizens in a large city: the Epidoso Project in São Paulo. Cad Saúde Pública. 2003;19(3):793–797. doi: 10.1590/S0102-311X2003000300011.
Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivelä SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55(8):809-817. doi: 110.1016/s0895-4356(02)00411-0.
Ramos LR, Tavares NUL, Bertoldi AD, Farias MR, Oliveira MA, Luiza VL, et al. Polypharmacy and polymorbidity in older adults in Brazil: a public health challenge. Rev Saúde Pública. 2016; 50:9s. doi: 10.1590/S1518-8787.2016050006145.
Lau SR, Waldorff F, Holm A, Frølich A, Andersen JS, Sallerup M, et al. Disentangling concepts of inappropriate polypharmacy in old age: a scoping review. BMC Public Health. 2023;23(1):245. doi: 10.1186/s12889-023-15013-2
Gosselin M, Talbot D, Simard M, Chiu YM, Mésidor M, Boiteau V, et al. Classifying Polypharmacy According to Pharmacotherapeutic and Clinical Risks in Older Adults: A Latent Class Analysis in Quebec, Canada. Drugs Aging. 2023;40(6):573-583. doi: 10.1007/s40266-023-01028-2.
Molist-Brunet N, Sevilla-Sánchez D, Puigoriol-Juvanteny E, Barneto-Soto M, González-Bueno J, Espaulella-Panicot J. Improving individualized prescription in patients with multimorbidity through medication review. BMC Geriatr. 2022;22(1):417. doi: 10.1186/s12877-022-03107-2.
Garcia KR, Bento AP, de Oliveira AG, da Silva RA, Chiarello MD, Chariglione IPFS, et al. COVID-19 and the elaboration of personal plans in + 50: a Brazilian experience. BMC Public Health.2023;23(1):221. doi: 10.1186/s12889-023-15006-1
Melo LA de, Lima KC de. Prevalência e fatores associados a multimorbidades em idosos brasileiros. Ciênc saúde coletiva. 2020;25(10):3869–3877. doi: 10.1590/1413-812320202510.34492018.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009; 42(2):377-381. doi: 10.1016/j.jbi.2008.08.010.
Meneses-Gaya C, Zuardi AW, Loureiro SR, Hallak JE, Trzesniak C, de Azevedo Marques JM, et al. Is the full version of the AUDIT really necessary? Study of the validity and internal construct of its abbreviated versions. Alcohol Clin Exp Res. 2010;34(8):1417-1424. doi: 10.1111/j.1530-0277.2010.01225.x.
WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification Index 2023. Oslo; 2023. Available from: http://www.whocc.no/atc_ddd_index/
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. doi: 10.1016/0021-9681(87)90171-8.
Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson Comorbidity Index: a critical review of Clinimetric Properties. Psychother Psychosom. 2022;91(1):8–35. doi: 10.1159/000521288.
Costa GM da, Oliveira MLC de, Novaes MRCG. Factors associated with polypharmacy among elderly people receiving care under the family health strategy. Rev bras geriatr gerontol. 2017;20(4):525–533. doi: 10.1590/1981-22562017020.170005.
Oliveira PC de, Silveira MR, Ceccato M das GB, Reis AMM, Pinto IVL, Reis EA. Prevalence and factors associated with polypharmacy among the elderly treated in Primary Healthcare in Belo Horizonte, State of Minas Gerais, Brazil. Ciênc saúde coletiva. 2021;26(4):1553–1564. doi: 10.1590/1413-81232021264.08472019.
Pereira KG, Peres MA, Iop D, Boing AC, Boing AF, Aziz M, et al. Polypharmacy among the elderly: a population-based study. Rev bras epidemiol. 2017;20(2):335–344. doi: 10.1590/1980-5497201700020013.
Rezende GR de, Amaral TLM, Amaral C de A, Vasconcellos MTL de, Monteiro GTR. Prevalence of polypharmacy and associated factors in older adults living in Rio Branco, Acre, Brazil: a cross-sectional population-based study, 2014. Epidemiol Serv Saúde. 2021;30(2):e2020386. doi: 10.1590/S1679-49742021000200013.
Barghouth MH, Schaeffner E, Ebert N, Bothe T, Schneider A, Mielke N. Polypharmacy and the Change of Self-Rated Health in Community-Dwelling Older Adults. Int J Environ Res Public Health. 2023;20(5):4159. doi: 10.3390/ijerph20054159.
Mangin D, Lamarche L, Agarwal G, Ali A, Cassels A, Colwill K, et al. Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy. Pilot Feasibility Stud. 2023;9(1):84. doi: 10.1186/s40814-023-01315-0.
Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827-834. doi: 10.1001/jamainternmed.2015.0324.
Molist-Brunet N, Sevilla-Sánchez D, Puigoriol-Juvanteny E, Barneto-Soto M, González-Bueno J, Espaulella-Panicot J. Improving individualized prescription in patients with multimorbidity through medication review. BMC Geriatr. 2022;22(1):417. doi: 10.1186/s12877-022-03107-2.
Baah-Nyarkoh E, Alhassan Y, Dwomoh AK, Kretchy IA. Medicated-related burden and adherence in patients with co-morbid type 2 diabetes mellitus and hypertension. Heliyon. 2023;13;9(4):e15448. doi: 10.1016/j.heliyon.2023.e15448.
Daunt R, Curtin D, O’Mahony D. Polypharmacy stewardship: a novel approach to tackle a major public health crisis. Lancet Healthy Longev. 2023;4(5):e228-e235. doi: 10.1016/S2666-7568(23)00036-3.
Abdoli N, Salari N, Darvishi N, Jafarpour S, Solaymani M, Mohammadi M, et al. The global prevalence of major depressive disorder (MDD) among the elderly: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2022; 132:1067-1073. doi: 10.1016/j.neubiorev.2021.10.041.
Qiao Y, Liu S, Zhang Y, Wu Y, Shen Y, Ke C. Bidirectional association between depression and multimorbidity in middle-aged and elderly Chinese adults: a longitudinal cohort study. Aging Ment Health. 2022; 26(4):784-790. doi: 10.1080/13607863.2021.1877609.
American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023. doi: 10.1111/jgs.18372.
Ishtiak-Ahmed K, Köhler-Forsberg O, Mortensen EL, Nierenberg AA, Gasse C. Concurrent use of polypharmacy and potentially inappropriate medications with antidepressants in older adults: A nationwide descriptive study in Denmark during 2015-2019. Gen Hosp Psychiatry. 2023; 82:66-74. doi: 10.1016/j.genhosppsych.2023.03.009.
Freire M de BO, Da Silva BGC, Bertoldi AD, Fontanella AT, Mengue SS, Ramos LR, et al. Benzodiazepines utilization in Brazilian older adults: a population-based study. Rev Saúde Pública. 2022; 56:10. doi: 10.11606/s1518-8787.2022056003740.
Eyigor S, Kutsal YG, Toraman F, Durmus B, Gokkaya KO, Aydeniz A, et al. Polypharmacy, physical and nutritional status, and depression in the elderly: do polypharmacy deserve some credits in these problems? Exp Aging Res. 2021; 47(1):79-91. doi: 10.1080/0361073X.2020.1846949.
Meng LC, Hsiao FY, Huang ST, Lu WH, Peng LN, Chen LK. Intrinsic Capacity Impairment Patterns and their Associations with Unfavorable Medication Utilization: A Nationwide Population-Based Study of 37,993 Community-Dwelling Older Adults. J Nutr Health Aging. 2022; 26(10):918-925. doi: 10.1007/s12603-022-1847-z.
Nascimento RCRM, Álvares J, Guerra Junior AA, Gomes IC, Silveira MR, Costa EA, et al. Polypharmacy: a challenge for the primary health care of the Brazilian Unified Health System. Rev Saúde Pública. 2017; 51:19s. doi: 10.11606/S1518-8787.2017051007136.
Marques PP, Assumpção D, Rezende R, Neri AL, Francisco PMSB. Polypharmacy in community-based older adults: results of the Fibra study. Rev bras geriatr gerontol. 2019; 22(5):e190118. doi: 10.1590/1981-22562019022.190118
Zhang L, Xu X. Construction of smart older adults care service model driven by primary health care. Front Public Health. 2023; 11:1157758. doi: 10.3389/fpubh.2023.1157758.
Oliveira REM, Ueta JM, Franco LJ. Variables associated with adherence to the treatment of type 2 diabetes mellitus among elderly people. Diabetol Int. 2021; 13(1):160-168. doi: 10.1007/s13340-021-00518-1.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Rinaldo Eduardo Machado de Oliveira, Vinícius Vieira da Costa, Camila de Oliveira Costa, Cássia Cristina de Paula Alves, Emília Vitória da Silva, Margô Gomes de Oliveira Karnikowski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
